SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 163 filers reported holding SYNDAX PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.68 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $131 | -30.7% | 9,023 | 0.0% | 0.00% | -50.0% |
| Q2 2023 | $189 | +37.0% | 9,023 | +37.9% | 0.00% | +100.0% |
| Q1 2023 | $138 | -24.2% | 6,541 | -8.5% | 0.00% | -50.0% |
| Q4 2022 | $182 | -99.9% | 7,148 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $172,000 | +29.3% | 7,148 | +3.1% | 0.00% | +100.0% |
| Q2 2022 | $133,000 | +30.4% | 6,936 | +18.0% | 0.00% | 0.0% |
| Q1 2022 | $102,000 | – | 5,880 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 956,165 | $20,930,000 | 11.19% |
| Aisling Capital Management LP | 1,025,000 | $22,437,000 | 7.92% |
| FRAZIER MANAGEMENT LLC | 2,772,062 | $60,680,000 | 4.67% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,176,585 | $25,755,000 | 2.83% |
| Paradigm Biocapital Advisors LP | 453,091 | $9,918,000 | 2.83% |
| Ghost Tree Capital, LLC | 300,000 | $6,567,000 | 2.35% |
| Avidity Partners Management LP | 4,823,400 | $105,584,000 | 2.24% |
| Nantahala Capital Management | 2,850,559 | $62,399,000 | 2.20% |
| ACUTA CAPITAL PARTNERS, LLC | 206,126 | $4,512,000 | 1.90% |
| BVF INC/IL | 2,099,714 | $45,963,000 | 1.67% |